Market+ (iPhone)

Market+ (Android)

US STOCKS

FUNDS

FX & CRYPTO

SH/SZ-HK

HK STOCKS

IPO Plus - IPO

To-be Listed

	Name▼ / Code▼	Industry	Offer Price	Lot Size	Entry Fee	Closing Date	Grey Market Date▼	Listing Date▲
No Upcoming IPO

Summary

We are a leading Hong Kong-based company that markets and distributes branded healthcare products with product footprint across Greater China, Southeast Asia and other select countries. In 2019, we ranked fourth by revenue among brand operators that carry both OTC proprietary medicines and OTC proprietary Chinese medicines in Hong Kong, according to the Frost & Sullivan Report. Our portfolio includes a wide range of quality branded healthcare products divided into two product categories: (i) consumer healthcare, consisting of branded medicines, which are proprietary medicines primarily distributed over-the-counter, and health and wellness products; and (ii) proprietary Chinese medicines, consisting of OTC proprietary Chinese medicines and concentrated Chinese medicine granules, or CCMG, products. Professionalism has been at the core of our corporate culture and our reputation is upheld through our persistence in product safety, efficacy and quality. We pride ourselves as a brand incubator and manager, with a proven track record of introducing well-established overseas branded products to our local markets, as well as rejuvenating heritage household brands to stimulate market demand and broaden their market appeal. We operate a vertically integrated business encompassing brand management and marketing, sourcing and representation of third-party brand products, development and manufacturing of own brand products, and sales and distribution. ‧ Brand management and marketing: We manage a portfolio of well-established and trusted third-party brands and own brands and are committed to continually driving brand engagement and sales through our multi-channel marketing campaigns. We seek to use our market and consumer insights to devise more precise product positioning and brand management strategies to improve our product appeal and consumer interests, and drive our product development initiatives. ‧ Sourcing and representation of third-party brand products: A majority of our consumer healthcare products are sourced from overseas third-party brand owners. As at March 31, 2020, we carried 11 principal third-party brands, the majority of which were sourced from Europe, including consumer healthcare products imported from reputable European GMP-accredited, ISO-certified or SGS-certified manufacturers. We generally obtain exclusive distribution rights from the third-party brand owners with which we enter into distributorship or in-licensing agreements for the sale and distribution of the relevant products in selected geographic markets. ‧ Development and manufacture of own brand products: As at March 31, 2020, we owned nine principal brands of branded healthcare products. The majority of our own brand products are OTC proprietary medicines and OTC proprietary Chinese medicines with long established proprietary formulations based on ancient prescriptions, pharmacopeia prescriptions or customary Chinese prescriptions. Tailored to the characteristics of our own brand product portfolio, our product development efforts have been directed towards product line extensions, formulation variations and formulation refinements for targeted overseas markets and expansion into new markets. ‧ Sales and distribution: We adopt a hybrid of sales and distribution models tailored for different products and geographic markets. In Hong Kong, we sell our products both directly and indirectly (through our Hong Kong Distributor and our trading company customers) to major modern trade chain stores, registered pharmacies and drug stores, as well as corporate clients, hospitals and clinics, and end consumers (through online platforms). In addition, we sell CCMG products to more than 3,000 Chinese medicine practitioners (which represented over 40% of the total number of active Chinese medicine practitioners in Hong Kong in 2019, according to the Frost & Sullivan Report), and from time to time, to non-profit organizations. Outside of Hong Kong, we sell selected products to China, Macau, Taiwan, and select countries in Southeast Asia, Europe, North America and the Caribbean Islands, primarily through distributorship and wholesaling arrangements. Meanwhile, we also devote dedicated resources to fulfill relevant product registration requirements and to closely monitor the regulatory regimes to ensure that our existing products and new products continue to comply with relevant product registration and product license requirements. ‧ Quality management: We enforce stringent quality assurance and control covering a wide range of activities, including procurement, manufacturing, release of finished products, stability studies, and validation and qualification of equipment and facilities. Our quality assurance personnel are responsible for ensuring GMP compliance, whereas our quality control personnel are responsible for arranging or carrying out all necessary and relevant tests on raw materials, manufacturing process, work in progress and finished products. Source: JBM Healthcare (02161) Prospectus (IPO Date : 2021/01/26)
Listing Market	MAIN
Industry	Health Care Supplies
Background	Others
Major Business Area	N/A

Corporate Information

Substantial Shareholders	Sum Kwong Yip, Derek (62.39%) Yunnan Baiyao Group Co., Ltd. (9.23%)
Directors	Sum Kwong Yip, Derek (Chairman and Non-Executive Director) Wong Yat Wai, Patrick (Chief Executive Officer and Executive Director) Cheng Celine Heung Kwan (Executive Director) Yeung Kwok Chun, Harry (Non-Executive Director) Yim Chun Leung (Non-Executive Director) Chan Kam Chiu, Simon (Independent Non-Executive Director) Lau Shut Lee, Tony (Independent Non-Executive Director) Luk Ting Lung, Alan (Independent Non-Executive Director)
Company Secretary	Yu Chun Kau
Principal Bankers	The HongKong and Shanghai Banking Corporation Limited Chong Hing Bank Limited Standard Chartered Bank (Hong Kong) Ltd.
Solicitors
Auditors	KPMG
Registered Office	Units 808-811, 8th Floor, C-Bons International Centre, 108 Wai Yip Street, Kwun Tong, Kowloon, Hong Kong
Share Registrars	Tricor Investor Services Ltd. [Tel: (852) 2980-1333]
Share Registrars Tel No	(852) 2980-1333
Internet Address	http://www.jbmhealthcare.com.hk
Email Address	enquiry@jbmhealthcare.com.hk
Tel No	(852) 2267-2182
Fax No

SITEMAP

AASTOCKS.com

Members

Forgot Password

About Us

Email: support@aastocks.com

AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.

Disclaimer

You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 6 January 2023.